Clinical trials
Intracranial Aneurysm trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 5 |
| 2016 | 6 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 9 |
| Unknown status | 7 |
| Active, not recruiting | 5 |
| Terminated | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Microvention-Terumo, Inc. | 5 |
| Stryker Neurovascular | 5 |
| Phenox GmbH | 4 |
| Balt Extrusion | 3 |
| Medtronic Neurovascular Clinical Affairs | 3 |
| Acandis GmbH | 2 |
| Cerus Endovascular, Inc. | 2 |
| Aesculap AG | 1 |
| Balt International | 1 |
| CENTOGENE GmbH Rostock | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intracranial Aneurysm | 43 |
| Aneurysm | 13 |
| Stroke | 3 |
| Cardiovascular Diseases | 2 |
| Intracranial Arterial Diseases | 2 |
| Ischemic Stroke | 2 |
| Nervous System Diseases | 2 |
| X-Linked Combined Immunodeficiency Diseases | 2 |
| Aneurysm, False | 1 |
| Arteriovenous Fistula | 1 |
Trials
Showing 76 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.